IRIS

Weide, B., Zelba, H., Derhovanessian, E., Pflugfelder, A., Schadendorf, D., de Vries, J., et al. (2011). Specific cellular immune responses against NY-ESO-1 are associated with favorable survival of stage IV melanoma patients. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 9(9), 781-782.

Specific cellular immune responses against NY-ESO-1 are associated with favorable survival of stage IV melanoma patients

Maio M;
2011-01-01
2011
Weide, B., Zelba, H., Derhovanessian, E., Pflugfelder, A., Schadendorf, D., de Vries, J., et al. (2011). Specific cellular immune responses against NY-ESO-1 are associated with favorable survival of stage IV melanoma patients. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 9(9), 781-782.
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1081065